The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Lung Market Research Report 2025
Synopsis
An artificial lung (AL) is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. The AL is intended to take over some of the functionality of biological lungs.
The global Artificial Lung market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Lung is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Lung is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Lung include ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical and The Charles Stark Draper Laboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Lung, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Lung.
Report Scope
The Artificial Lung market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Lung market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Lung manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALung Technologies
Breethe
Haemair
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray
Michigan Critical Care Consultants
Miromatrix Medical
The Charles Stark Draper Laboratory
Xenios
Segment by Type
Bubble Artificial Lung
Membrane Artificial Lung
Segment by Application
Hospital
Emergency Center
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Lung manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Lung in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An artificial lung (AL) is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. The AL is intended to take over some of the functionality of biological lungs.
The global Artificial Lung market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Lung is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Lung is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Lung include ALung Technologies, Breethe, Haemair, Lung Biotechnology PBC, McGowan Institute for Regenerative Medicine, MedArray, Michigan Critical Care Consultants, Miromatrix Medical and The Charles Stark Draper Laboratory, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Lung, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Lung.
Report Scope
The Artificial Lung market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Lung market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Lung manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ALung Technologies
Breethe
Haemair
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray
Michigan Critical Care Consultants
Miromatrix Medical
The Charles Stark Draper Laboratory
Xenios
Segment by Type
Bubble Artificial Lung
Membrane Artificial Lung
Segment by Application
Hospital
Emergency Center
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Lung manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Lung in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Lung Market Overview
1.1 Product Overview and Scope of Artificial Lung
1.2 Artificial Lung Segment by Type
1.2.1 Global Artificial Lung Market Value Comparison by Type (2024-2030)
1.2.2 Bubble Artificial Lung
1.2.3 Membrane Artificial Lung
1.3 Artificial Lung Segment by Application
1.3.1 Global Artificial Lung Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Emergency Center
1.3.4 Other
1.4 Global Artificial Lung Market Size Estimates and Forecasts
1.4.1 Global Artificial Lung Revenue 2019-2030
1.4.2 Global Artificial Lung Sales 2019-2030
1.4.3 Global Artificial Lung Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Lung Market Competition by Manufacturers
2.1 Global Artificial Lung Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Lung Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Lung Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Lung Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Lung, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Lung, Product Type & Application
2.7 Artificial Lung Market Competitive Situation and Trends
2.7.1 Artificial Lung Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Lung Players Market Share by Revenue
2.7.3 Global Artificial Lung Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Lung Retrospective Market Scenario by Region
3.1 Global Artificial Lung Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Lung Global Artificial Lung Sales by Region: 2019-2030
3.2.1 Global Artificial Lung Sales by Region: 2019-2024
3.2.2 Global Artificial Lung Sales by Region: 2025-2030
3.3 Global Artificial Lung Global Artificial Lung Revenue by Region: 2019-2030
3.3.1 Global Artificial Lung Revenue by Region: 2019-2024
3.3.2 Global Artificial Lung Revenue by Region: 2025-2030
3.4 North America Artificial Lung Market Facts & Figures by Country
3.4.1 North America Artificial Lung Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Lung Sales by Country (2019-2030)
3.4.3 North America Artificial Lung Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Lung Market Facts & Figures by Country
3.5.1 Europe Artificial Lung Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Lung Sales by Country (2019-2030)
3.5.3 Europe Artificial Lung Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Lung Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Lung Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Lung Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Lung Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Lung Market Facts & Figures by Country
3.7.1 Latin America Artificial Lung Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Lung Sales by Country (2019-2030)
3.7.3 Latin America Artificial Lung Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Lung Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Lung Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Lung Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Lung Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Lung Sales by Type (2019-2030)
4.1.1 Global Artificial Lung Sales by Type (2019-2024)
4.1.2 Global Artificial Lung Sales by Type (2025-2030)
4.1.3 Global Artificial Lung Sales Market Share by Type (2019-2030)
4.2 Global Artificial Lung Revenue by Type (2019-2030)
4.2.1 Global Artificial Lung Revenue by Type (2019-2024)
4.2.2 Global Artificial Lung Revenue by Type (2025-2030)
4.2.3 Global Artificial Lung Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Lung Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Lung Sales by Application (2019-2030)
5.1.1 Global Artificial Lung Sales by Application (2019-2024)
5.1.2 Global Artificial Lung Sales by Application (2025-2030)
5.1.3 Global Artificial Lung Sales Market Share by Application (2019-2030)
5.2 Global Artificial Lung Revenue by Application (2019-2030)
5.2.1 Global Artificial Lung Revenue by Application (2019-2024)
5.2.2 Global Artificial Lung Revenue by Application (2025-2030)
5.2.3 Global Artificial Lung Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Lung Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ALung Technologies
6.1.1 ALung Technologies Corporation Information
6.1.2 ALung Technologies Description and Business Overview
6.1.3 ALung Technologies Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ALung Technologies Artificial Lung Product Portfolio
6.1.5 ALung Technologies Recent Developments/Updates
6.2 Breethe
6.2.1 Breethe Corporation Information
6.2.2 Breethe Description and Business Overview
6.2.3 Breethe Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Breethe Artificial Lung Product Portfolio
6.2.5 Breethe Recent Developments/Updates
6.3 Haemair
6.3.1 Haemair Corporation Information
6.3.2 Haemair Description and Business Overview
6.3.3 Haemair Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Haemair Artificial Lung Product Portfolio
6.3.5 Haemair Recent Developments/Updates
6.4 Lung Biotechnology PBC
6.4.1 Lung Biotechnology PBC Corporation Information
6.4.2 Lung Biotechnology PBC Description and Business Overview
6.4.3 Lung Biotechnology PBC Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lung Biotechnology PBC Artificial Lung Product Portfolio
6.4.5 Lung Biotechnology PBC Recent Developments/Updates
6.5 McGowan Institute for Regenerative Medicine
6.5.1 McGowan Institute for Regenerative Medicine Corporation Information
6.5.2 McGowan Institute for Regenerative Medicine Description and Business Overview
6.5.3 McGowan Institute for Regenerative Medicine Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.5.4 McGowan Institute for Regenerative Medicine Artificial Lung Product Portfolio
6.5.5 McGowan Institute for Regenerative Medicine Recent Developments/Updates
6.6 MedArray
6.6.1 MedArray Corporation Information
6.6.2 MedArray Description and Business Overview
6.6.3 MedArray Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MedArray Artificial Lung Product Portfolio
6.6.5 MedArray Recent Developments/Updates
6.7 Michigan Critical Care Consultants
6.6.1 Michigan Critical Care Consultants Corporation Information
6.6.2 Michigan Critical Care Consultants Description and Business Overview
6.6.3 Michigan Critical Care Consultants Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Michigan Critical Care Consultants Artificial Lung Product Portfolio
6.7.5 Michigan Critical Care Consultants Recent Developments/Updates
6.8 Miromatrix Medical
6.8.1 Miromatrix Medical Corporation Information
6.8.2 Miromatrix Medical Description and Business Overview
6.8.3 Miromatrix Medical Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Miromatrix Medical Artificial Lung Product Portfolio
6.8.5 Miromatrix Medical Recent Developments/Updates
6.9 The Charles Stark Draper Laboratory
6.9.1 The Charles Stark Draper Laboratory Corporation Information
6.9.2 The Charles Stark Draper Laboratory Description and Business Overview
6.9.3 The Charles Stark Draper Laboratory Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.9.4 The Charles Stark Draper Laboratory Artificial Lung Product Portfolio
6.9.5 The Charles Stark Draper Laboratory Recent Developments/Updates
6.10 Xenios
6.10.1 Xenios Corporation Information
6.10.2 Xenios Description and Business Overview
6.10.3 Xenios Artificial Lung Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xenios Artificial Lung Product Portfolio
6.10.5 Xenios Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Lung Industry Chain Analysis
7.2 Artificial Lung Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Lung Production Mode & Process
7.4 Artificial Lung Sales and Marketing
7.4.1 Artificial Lung Sales Channels
7.4.2 Artificial Lung Distributors
7.5 Artificial Lung Customers
8 Artificial Lung Market Dynamics
8.1 Artificial Lung Industry Trends
8.2 Artificial Lung Market Drivers
8.3 Artificial Lung Market Challenges
8.4 Artificial Lung Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
